LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/People In The News/Lukianov Joins Orthofix Board
People In The News

Lukianov Joins Orthofix Board

December 22, 2016 1 min read Premium comments

Advertisement

Lukianov Joins Orthofix Board
Alex Lukianov

Alex Lukianov is back in spine.

Orthofix International N.V. announced on December 13, 2016, that Lukianov is now one of the company’s board members. His appointment expands Orthofix’s board to 10 directors, of which 9 are independent.

Lukianov is darn near a legend in spine after leaving Medtronic SofamorDanek and revitalizing a little San Diego start-up, called NuVasive, Inc.

When Lukianov joined NuVasive in 1999 (two years after it was founded) the company had no sales and was losing about $6 million a year. The next year NuVasive sold $52, 000 of classic spine fusion products—and lost $14 million.

When he suddenly and unexpectedly resigned 16 years later, NuVasive employed 1, 500 people, was the third largest spinal implant supplier in the world with annual sales in excess of $760 million and had a market value of more than $2 billion.

Lukianov has over 30 years’ experience with senior executive positions with Medtronic and Smith & Nephew Orthopaedics, where he was the director of a business unit that brought limb lengthening technology to the U.S. from Russia. He was the founder of and served as the chairman of the Board and CEO of BackCare Group, Inc., a spine physician practice management company, and from 1999-2015 he was the chairman and CEO at NuVasive. He’s served on a variety of public, private and not-for-profit boards including the Volcano Corporation, the California Health Institute, BIOCOM, and the Medical Device Manufacturers Association (MDMA).

On a personal note, he’s also a mean bass in various chorale groups and produced orthodox liturgical music CDs and concert tours for the Patriarch Tikhon Choir. He followed that with producing the Broadway musical, MEMPHIS, which won a Tony Award. The Russian immigrant studied at Rutgers University and served four years in the U.S. Navy as a hospital corpsman and surgical technologist.

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy